Actively Recruiting
Improving Outcomes for Patients With Critical Bleeding Requiring Massive Transfusion
Led by Monash University · Updated on 2020-09-02
50000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
M
Monash University
Lead Sponsor
C
CSL Behring
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are gathering detailed information about patients who have experienced severe bleeding that required a massive transfusion, such as after serious injury, surgery, or childbirth. This observational study collects and analyzes data to better understand how often these events occur, what happens to patients, and how blood transfusions are used in these situations. The study is conducted by Monash University and includes data from multiple hospitals in Australia and New Zealand. The study uses electronic methods to collect existing clinical data from hospital databases, including transfusion records and patient demographics. This information is securely linked and analyzed to provide insights into transfusion practices and patient outcomes after critical bleeding events. The registry includes data from over 6,000 patients across 25 sites, covering various clinical settings such as trauma, surgery, obstetrics, and gastrointestinal bleeding. Participants in this study are adults who experienced critical bleeding and received at least five units of red blood cells within four hours. The study monitors outcomes such as mortality within 30 days after the bleeding event. Data linkage with national death indexes and other registries helps provide comprehensive outcome measurements. The study allows ongoing collection and analysis of data to improve transfusion policies and patient care practices over time.
CONDITIONS
Brief Title
Australian and New Zealand Massive Transfusion Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 years or over
- Received 5 or more units of red blood cells in any 4 hour period
You will not qualify if you...
- None
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to several years depending on data availability
Participants who have experienced critical bleeding and massive transfusion are observed through data collected from hospital records and registries to analyze transfusion practices and patient outcomes.
Trial Site Locations
Total: 1 location
1
Monash University
Melbourne, Victoria, Australia, 3004
Actively Recruiting
Research Team
E
Erica Wood, MBBS
R
Rosemary Sparrow, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here